B cell reductive therapy with rituximab in the treatment of rheumatoid arthritis.
The approach to treating autoimmune disorders is currently undergoing a significant change in focus. As therapies are developed that are more precise in targeting the pathogenesis for these diseases, patients experience significantly fewer side effects. At the same time, as more precise therapies are discovered, the etiologies of these diseases become further elucidated. It is now widely accepted that B-lymphocytes play a significant role in the pathogenesis of various autoimmune diseases, the extent of which continues to be the focus of ongoing research. Rheumatoid arthritis is one such disease process that has been the focus of various B-lymphocyte-directed therapeutic trials. In this paper we review the current research available on rituximab as treatment for rheumatoid arthritis. This review details results from four main studies, as well as others, which used rituximab in at least one of the arms in treatment of rheumatoid arthritis. The results are promising and will likely lead to longer term studies as well as a potential focus on B cell subsets.
Tuscano
Joseph M
JM
Hematology and Oncology, Veterans Affairs, Northern California Health Care System, California, USA; Division of Hematology and Oncology, University of California, Davis School of Medicine, Sacramento, California, USA. joseph.tuscano@ucdmc.ucdavis.edu
Sands
Jacob
J
Intern Med. 2007;46(16):1313-5
17704614
Ann N Y Acad Sci. 1995 Sep 29;764:440-9
7486562
J Clin Pharmacol. 2005 Jul;45(7):792-801
15951469
Ann Rheum Dis. 2008 Mar;67(3):402-8
17644541
N Engl J Med. 2004 Jun 17;350(25):2572-81
15201414
Clin Immunol. 2003 Jun;107(3):140-51
12804527
J Pediatr Hematol Oncol. 2003 Dec;25 Suppl 1:S57-61
14668642
J Exp Med. 1999 May 17;189(10):1639-48
10330443
Annu Rev Immunol. 2001;19:275-90
11244038
Blood. 2001 Aug 15;98(4):952-7
11493438
Arthritis Rheum. 2008 Oct;58(10):2993-9
18821683
Arthritis Res Ther. 2004;6(4):R303-8
15225365
J Rheumatol. 2005 Nov;32(11):2109-15
16265687
Neurology. 2003 Dec 23;61(12):1652-61
14694025
Nat Clin Pract Rheumatol. 2007 May;3(5):262-72
17471245
Haematologica. 2003 May;88(5):538-46
12745273
Blood. 2001 Apr 1;97(7):2171-2
11264188
J Allergy Clin Immunol. 2003 Apr;111(4):697-703
12704346
Br J Haematol. 2004 Apr;125(2):232-9
15059147
Arthritis Rheum. 2005 Aug;52(8):2506-12
16052584
N Engl J Med. 2003 Jun 19;348(25):2543-56
12815141
Arthritis Rheum. 2004 Apr;50(4):1051-65
15077287
Arthritis Rheum. 2004 May;50(5):1400-11
15146409
Arthritis Rheum. 2008 Dec;58(12):3657-64
19035505
Arthritis Rheum. 2003 Oct;48(10):2741-9
14558078
Semin Oncol. 2000 Dec;27(6 Suppl 12):17-24
11225995
Clin Ther. 2000 Jan;22(1):128-39
10688396
J Rheumatol. 2008 Jan;35(1):20-30
18050385
Med Care. 2005 Jan;43(1):79-87
15626937
N Engl J Med. 2002 Jan 24;346(4):235-42
11807147
Ann Intern Med. 2007 Jun 5;146(11):797-808
17548411
J Exp Med. 1994 Oct 1;180(4):1295-306
7931063
J Autoimmun. 1997 Feb;10(1):87-97
9080303
Arthritis Rheum. 2008 Jun;58(6):1566-75
18512772
Ann Rheum Dis. 2008 Jul;67(7):917-25
17965121
Arthritis Rheum. 2007 Mar;56(3):772-8
17328049
Science. 2001 Jan 19;291(5503):484-6
11161202
Arthritis Rheum. 2006 Sep;54(9):2793-806
16947627
Ann Rheum Dis. 2009 Feb;68(2):216-21
18388156
Arthritis Rheum. 2006 May;54(5):1390-400
16649186
N Engl J Med. 2001 Aug 2;345(5):340-50
11484692
J Clin Oncol. 1998 Aug;16(8):2825-33
9704735
Semin Oncol. 2000 Dec;27(6 Suppl 12):99-103
11226008
Rheumatology (Oxford). 2006 Dec;45(12):1505-13
17062648
J Clin Pharmacol. 2007 Sep;47(9):1119-28
17766699